Ethics/Regulatory

FDA to post inspection information online

Thursday, June 2, 2011 01:46 PM

The FDA will publish more details about inspections and court actions on its web site as part of a drive toward transparency, according to a report on InPharm.

More... »


U.S. R&D productivity often undercounted, as most reports omit FDA biologics approvals

Tuesday, May 31, 2011 09:44 AM

Most reports of pharmaceutical R&D productivity undercount the number of new drugs that reach the market each year, missing out on billions of dollars of sales, because they omit approvals from the Food and Drug Administration’s (FDA) biologics division, according to a new report by London-based research company EvaluatePharma.

More... »


Industry groups want to be heard on the impact of sunshine law before new regulations are finalized

Monday, May 16, 2011 09:36 AM

The so-called sunshine law, which requires drug sponsors to publicly disclose payments to physicians and teaching hospitals, will present significant operational challenges to biopharmaceutical companies and contract research organizations (CROs) when data collection requirements go into effect in January 2012. However, industry groups worry their concerns about how the law could affect clinical research won’t adequately be taken into account as the rule and its regulations are finalized during the next four months.

More... »

Chile's plans to create drug regulatory agency

Monday, May 9, 2011 01:10 PM

The Chilean parliament will examine legislation for a national medicines agency, which is good news for global drugmakers, according to Pharma Times.

More... »

Biotechs say FDA regulations impede job creation

Friday, April 22, 2011 12:13 PM

Drug and medical device companies are having a hard time creating jobs and delivering innovative new therapies to patients because of tight government regulations, limits in science and research funding and high taxes reported biotech industry leaders at a recent congressional hearing in San Diego, according to The San Diego Union-Tribune.

More... »

Anulex Techonologies will layoff workers

Wednesday, April 20, 2011 11:28 AM

Minnesota-based Anulex Techonologies will layoff workers after receiving a warning letter from the FDA in February, 2011, according to Fierce Medical Devices

More... »

U.S. government threatens to bar Forest CEO

Friday, April 15, 2011 12:27 PM

U.S. officials have sent a letter to Forest Laboratories chief executive Howard Solomon threatening him with a ban from participating in Medicare and Medicaid, according to Pharma Times.

More... »

Government shutdown could force FDA to cut staff

Friday, April 8, 2011 11:16 AM

Officials working with the FDA warned that the looming government shutdown will severely restrict food and drug inspections, according to a CNN Money report.

More... »

Pharmas eagerly await FDA guidance on social media

Thursday, April 7, 2011 11:01 AM

As the FDA further delays its eagerly-awaited draft guidance on social media, U.S. drugmakers have pointed to the "incredible potential public health benefits" of using electronic media in health care, according to Pharma Times.

More... »

Family medicine residencies reject pharma relationships

Tuesday, March 29, 2011 10:28 AM

Family medicine resident programs in the U.S. have limits on drug industry interaction with doctors, and several shun doctor-company relationships altogether.

More... »

`

CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs